BRAF gene mutation (V600E) in aspiration cytology of patients with suspected papillary thyroid carcinoma

Abstract   Introduction: This study was attempted to investigate the prevalence of BRAF gene mutation (V600E) in aspiration cytology of patients with suspected papillary thyroid carcinoma (PTC). Materials and methods: Seventy six Patients suspected of having PTC who referred for fine needle...

Full description

Bibliographic Details
Main Authors: Mohammadhossein Dadgarnia, Mohsen Abouii, Mohammadhossein Baradaranfar, Sedighe Vaziribozorg, Vahid Zand
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2021-10-01
Series:Acta Medica Iranica
Subjects:
Online Access:https://acta.tums.ac.ir/index.php/acta/article/view/8828
_version_ 1818775711773622272
author Mohammadhossein Dadgarnia
Mohsen Abouii
Mohammadhossein Baradaranfar
Sedighe Vaziribozorg
Vahid Zand
author_facet Mohammadhossein Dadgarnia
Mohsen Abouii
Mohammadhossein Baradaranfar
Sedighe Vaziribozorg
Vahid Zand
author_sort Mohammadhossein Dadgarnia
collection DOAJ
description Abstract   Introduction: This study was attempted to investigate the prevalence of BRAF gene mutation (V600E) in aspiration cytology of patients with suspected papillary thyroid carcinoma (PTC). Materials and methods: Seventy six Patients suspected of having PTC who referred for fine needle aspiration (FNA) biopsy were included in this cross-sectional study. Ultrasound-guided FNA was taken from the thyroid masses and samples were sent for cytologic evaluation. Simultaneously, the samples were sent to a genetic laboratory to check the status of BRAFV600E mutation. Patients with FNA positive for PTC were assigned in one group and those with FNA negative for PTC were assigned in other group. Cytological and molecular results were compared with those of histopathology and sonography. Results: The results showed that the prevalence of the BRAF gene (V600E) mutation in our study was 21.1% (16 out of 76 patients). In addition the results showed a significant relation between gene mutation and pathologic findings so that the highest gene mutation was significantly detected in patients with FNA positive for PTC (p.value=0.001). Also, our results showed a significant relation between gene mutation and some sonographic findings (calcification, p.value=0.004) and no significant relation in the other sonographic findings (hypo echoic changes, p.value=1.12 and regular changes, p.value=0.194). Conclusion: According to the results of the present study, BRAF mutation (V600E) can be an effective indicator for definitive diagnosis and primary treatment of PTC in suspected cases.
first_indexed 2024-12-18T11:01:23Z
format Article
id doaj.art-42f6308a0e874c7cbe056f8b32efb99d
institution Directory Open Access Journal
issn 0044-6025
1735-9694
language English
last_indexed 2024-12-18T11:01:23Z
publishDate 2021-10-01
publisher Tehran University of Medical Sciences
record_format Article
series Acta Medica Iranica
spelling doaj.art-42f6308a0e874c7cbe056f8b32efb99d2022-12-21T21:10:12ZengTehran University of Medical SciencesActa Medica Iranica0044-60251735-96942021-10-01599BRAF gene mutation (V600E) in aspiration cytology of patients with suspected papillary thyroid carcinomaMohammadhossein Dadgarnia0Mohsen Abouii1Mohammadhossein Baradaranfar2Sedighe Vaziribozorg3Vahid Zand41. Department of Otolaryngology- Head and Neck Surgery, Otorhinolaryngology Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, IranDepartment of Otolaryngology-Head and Neck Surgery, Otorhinolaryngology Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.1. Department of Otolaryngology- Head and Neck Surgery, Otorhinolaryngology Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran1. Department of Otolaryngology- Head and Neck Surgery, Otorhinolaryngology Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran1. Department of Otolaryngology- Head and Neck Surgery, Otorhinolaryngology Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, IranAbstract   Introduction: This study was attempted to investigate the prevalence of BRAF gene mutation (V600E) in aspiration cytology of patients with suspected papillary thyroid carcinoma (PTC). Materials and methods: Seventy six Patients suspected of having PTC who referred for fine needle aspiration (FNA) biopsy were included in this cross-sectional study. Ultrasound-guided FNA was taken from the thyroid masses and samples were sent for cytologic evaluation. Simultaneously, the samples were sent to a genetic laboratory to check the status of BRAFV600E mutation. Patients with FNA positive for PTC were assigned in one group and those with FNA negative for PTC were assigned in other group. Cytological and molecular results were compared with those of histopathology and sonography. Results: The results showed that the prevalence of the BRAF gene (V600E) mutation in our study was 21.1% (16 out of 76 patients). In addition the results showed a significant relation between gene mutation and pathologic findings so that the highest gene mutation was significantly detected in patients with FNA positive for PTC (p.value=0.001). Also, our results showed a significant relation between gene mutation and some sonographic findings (calcification, p.value=0.004) and no significant relation in the other sonographic findings (hypo echoic changes, p.value=1.12 and regular changes, p.value=0.194). Conclusion: According to the results of the present study, BRAF mutation (V600E) can be an effective indicator for definitive diagnosis and primary treatment of PTC in suspected cases.https://acta.tums.ac.ir/index.php/acta/article/view/8828papillary thyroid cancerfine needle aspirationBRAF gene (V600E) mutationultrasound
spellingShingle Mohammadhossein Dadgarnia
Mohsen Abouii
Mohammadhossein Baradaranfar
Sedighe Vaziribozorg
Vahid Zand
BRAF gene mutation (V600E) in aspiration cytology of patients with suspected papillary thyroid carcinoma
Acta Medica Iranica
papillary thyroid cancer
fine needle aspiration
BRAF gene (V600E) mutation
ultrasound
title BRAF gene mutation (V600E) in aspiration cytology of patients with suspected papillary thyroid carcinoma
title_full BRAF gene mutation (V600E) in aspiration cytology of patients with suspected papillary thyroid carcinoma
title_fullStr BRAF gene mutation (V600E) in aspiration cytology of patients with suspected papillary thyroid carcinoma
title_full_unstemmed BRAF gene mutation (V600E) in aspiration cytology of patients with suspected papillary thyroid carcinoma
title_short BRAF gene mutation (V600E) in aspiration cytology of patients with suspected papillary thyroid carcinoma
title_sort braf gene mutation v600e in aspiration cytology of patients with suspected papillary thyroid carcinoma
topic papillary thyroid cancer
fine needle aspiration
BRAF gene (V600E) mutation
ultrasound
url https://acta.tums.ac.ir/index.php/acta/article/view/8828
work_keys_str_mv AT mohammadhosseindadgarnia brafgenemutationv600einaspirationcytologyofpatientswithsuspectedpapillarythyroidcarcinoma
AT mohsenabouii brafgenemutationv600einaspirationcytologyofpatientswithsuspectedpapillarythyroidcarcinoma
AT mohammadhosseinbaradaranfar brafgenemutationv600einaspirationcytologyofpatientswithsuspectedpapillarythyroidcarcinoma
AT sedighevaziribozorg brafgenemutationv600einaspirationcytologyofpatientswithsuspectedpapillarythyroidcarcinoma
AT vahidzand brafgenemutationv600einaspirationcytologyofpatientswithsuspectedpapillarythyroidcarcinoma